Today we announced positive topline results from the first Phase 1b clinical trial of elecoglipron conducted in China in adults living with obesity/overweight, with or without type 2 diabetes
A small clinical trial confirmed these findings, showing that exenatide, another GLP-1 agonist, significantly reduced intracranial pressure in patients with idiopathic intracranial hypertension, greatly improving headache symptoms
Callewaert, C., Hutapea, P., Van De Wiele, T., & Boon, N
The hypoglycemia occurring with PGBH is treated differently than the hypoglycemia that occurs in diabetic patients
Understand the step-by-step process of your first appointment
doi: 10.2174/187152011795677544